SCHEMBL20715260

SCHEMBL20715260

c1ccc2c(c1)oc1ccc(-c3ccc4c(c3)c3ccccc3n4-c3nc(-c4ccc5oc6ccccc6c5c4)nc(-c4ccc5oc6ccccc6c5c4)n3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.41
MAPT P10636 3/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 1/20 0.40
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
AHR P35869 2/20 0.36
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
PLA2G10 O15496 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9881129 0.96 CHEK2 (0.39) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL24303517 0.95 PLA2G2A (0.40) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL22195781 0.95 PLA2G2A (0.40) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL16812258 0.95 PLA2G2A (0.40) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL17616865 0.95 PLA2G2A (0.40) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL18565661 0.94 MAPT (0.41) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL15294004 0.94 PLA2G2A (0.41) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL20634237 0.94 PLA2G2A (0.41) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL23318323 0.94 PLA2G2A (0.41) CHEK2MAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL22737690 0.93 CHEK2 (0.41) CHEK2MAPTALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2019-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS BRD3, BRPF3, DDT CHEK2 1190/4885MAPT 1546/4885ALDH1A1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.